| Date Filed | Type | Description |
| 05/19/2023 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 3,454 options to buy
@ $189.87, valued at
$655.8k
|
|
| 02/27/2023 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Exercised 136 restricted stock units
@ $0 |
|
| 06/16/2022 |
4
| SCHULMAN AMY W (10% Owner) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Granted 20,000 options
@ $3.23, valued at
$64.6k
|
|
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2021 |
4
| SCHULMAN AMY W (10% Owner) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Exercised 10,091 options
@ $2.02, valued at
$20.4k
Exercised 7,458 options
@ $4.59, valued at
$34.2k
Exercised 6,581 options
@ $4.59, valued at
$30.2k
|
|
| 12/15/2021 |
4
| SCHULMAN AMY W (10% Owner) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Bought 1,850 shares
@ $10.88, valued at
$20.1k
Bought 1,850 shares
@ $10.94, valued at
$20.2k
|
|
| 10/29/2021 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 1,814 options to buy
@ $191.16, valued at
$346.8k
|
|
| 07/19/2021 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 4,032 options to buy
@ $171.95, valued at
$693.3k
|
|
| 06/17/2021 |
4
| SCHULMAN AMY W (10% Owner) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Granted 10,500 options
@ $13.57, valued at
$142.5k
|
|
| 04/14/2021 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on Hudson Executive Investment Corp. II|
Txns:
| Bought 20,000 options to buy
@ $0.0029, valued at
$58 |
|
| 01/25/2021 |
3
| SCHULMAN AMY W (Director) has filed a Form 3 on Hudson Executive Investment Corp. II |
| 11/03/2020 |
4
| SCHULMAN AMY W (10% Owner) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Converted 22,204 shares
@ $0
Converted 161,994 shares
@ $0
Converted 2,315,652 shares
@ $0
Converted 275,860 shares
@ $0
Bought 16,346 shares
@ $16, valued at
$261.5k
Bought 233,654 shares
@ $16, valued at
$3.7M
Converted 28,863 convertible preferred
@ $0
Converted 412,608 convertible preferred
@ $0
Converted 56,462 convertible preferred
@ $0
Converted 807,096 convertible preferred
@ $0
Converted 44,120 convertible preferred
@ $0 |
|
| 10/30/2020 |
4
| SCHULMAN AMY W (10% Owner) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Granted 7,055 options
@ $16, valued at
$112.9k
|
|
| 10/29/2020 |
3
| SCHULMAN AMY W (10% Owner) has filed a Form 3 on SQZ Biotechnologies Co |
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $4.46, valued at
$44.6k
|
|
| 06/08/2020 |
3
| SCHULMAN AMY W (Director) has filed a Form 3 on Hudson Executive Investment Corp. |
| 07/02/2019 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 9,000 options to buy
@ $72.01, valued at
$648.1k
|
|
| 06/04/2019 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $13.95, valued at
$139.5k
|
|
| 04/10/2019 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Bought 604,482 shares
@ $16, valued at
$9.7M
Bought 21,635 shares
@ $16, valued at
$346.2k
|
|
| 04/03/2019 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Granted 4,229 shares
@ $0
Granted 3,279 shares
@ $0 |
|
| 04/03/2019 |
3
| SCHULMAN AMY W (Director) has filed a Form 3 on Cyclerion Therapeutics, Inc. |
| 04/03/2019 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Disposed/sold 4,056 shares
@ $0 |
|
| 03/19/2019 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 183 shares
@ $0 |
|
| 12/18/2018 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 212 shares
@ $0 |
|
| 09/18/2018 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 136 shares
@ $0 |
|
| 06/22/2018 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 9,000 options to buy
@ $105.26, valued at
$947.3k
|
|
| 06/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2018 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on Arsanis, Inc.|
Txns:
| Granted 10,000 options to buy
@ $16.99, valued at
$169.9k
|
|
| 06/04/2018 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 16,223 shares
@ $0 |
|
| 04/24/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2018 |
4/A
| SCHULMAN AMY W (Director) has filed a Form 4 on Arsanis, Inc.|
Txns:
| Granted 25,000 options to buy
@ $10, valued at
$250k
|
|
| 12/01/2017 |
4
| SCHULMAN AMY W (Director) has filed a Form 4 on Arsanis, Inc.|
Txns:
| Granted 7,324 options to buy
@ $10, valued at
$73.2k
|
|
|